Related Experiment Videos
Leukocyte-endothelial interactions in environmental hypoxia
1Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, USA.
Advances in Experimental Medicine and Biology
|April 13, 2002
Summary
Hypoxia initially triggers microvascular inflammation via reactive oxygen species (ROS). Acclimatization restores balance by upregulating nitric oxide (NO) synthase, resolving inflammation and preventing altitude sickness.
Area of Science:
- Physiology
- Pathophysiology
- Altitude Medicine
Background:
- Hypoxia, or low oxygen, rapidly affects microcirculation, increasing leukocyte activity and vascular permeability.
- This response is generalized across various microvascular beds.
Purpose of the Study:
- To investigate the microvascular response to hypoxia and the mechanisms of acclimatization.
- To understand the role of reactive oxygen species (ROS) and nitric oxide (NO) in hypoxia-induced inflammation and resolution.
Main Methods:
- Inducing hypoxia by reducing inspired oxygen partial pressure (PIO2).
- Observing microvascular responses (leukocyte rolling, adherence, emigration, vascular permeability).
- Measuring reactive oxygen species (ROS) and nitric oxide (NO) levels, and assessing the effects of antioxidants and nitric oxide synthase inhibitors.
Main Results:
- Initial hypoxia (PIO2 70 Torr) caused increased leukocyte-endothelial interactions and vascular permeability, linked to a rise in ROS.
- Acclimatization to hypoxia (3 weeks) resolved these responses, even with further PIO2 reduction (50 Torr).
- Acclimatization involved inducible nitric oxide synthase (iNOS) upregulation; iNOS inhibition exacerbated leukocyte-endothelial interactions and ROS.
Conclusions:
- Hypoxia initially disrupts the ROS/NO balance, leading to microvascular inflammation.
- Acclimatization restores the ROS/NO balance, likely through iNOS upregulation, resolving inflammation.
- These findings are relevant to altitude-related illnesses like acute mountain sickness and edema.